- Category
- Micro (2021-22)
- Udyam number
- UDYAM-UK-06-0011110

Fierce One Pharmaceuticals Private Limited
About Fierce One Pharmaceuticals Private Limited
Data last updated:
Fierce One Pharmaceuticals Private Limited is a private limited company based in Roorkee, Uttarakhand, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 16 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24239UR2021PTC013370.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Utkarsh Singh and Meenakshi Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No – 1075M 1076M 7081M Village Salempur Rajputana, Industrial Area Roorkee, Uttarakhand, India – 247667.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.72 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹70,937 (net margin -0.2%) and EBITDA of ₹6.57 Lakh (EBITDA margin 1.8%).
The company has about 16 employees on its provident fund (EPFO) records.
Court records list 22 cases involving the company, including 15 filed by the company and 7 filed against it; 16 cases are pending.
Fierce One Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0011110). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Fierce One Pharmaceuticals
Contact details
Fierce One Pharmaceuticals Private Limited's registered office is in Roorkee, Uttarakhand.
- Registered AddressKhasra No – 1075M 1076M 7081M Village Salempur Rajputana, Industrial Area Roorkee, Uttarakhand, India – 247667
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fierce One Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fierce One Pharmaceuticals Private Limited, buy the company report.
Financials of Fierce One Pharmaceuticals Private Limited
FY 2025 filings availableFierce One Pharmaceuticals Private Limited reported revenue of ₹3.72 Cr (down 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 20% in the latest year. EBITDA rose 105% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹6.57 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹70,937 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.8% | ||
| Net Profit Margin | -0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Fierce One Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fierce One Pharmaceuticals Private Limited
Fierce One Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Utkarsh Singh Also directs: Ravian Pharmaceuticals Limited, Balaji Pharmatech Private Limited | Director | 16 Dec 2021 | 4 Years 10 Months | Current |
| Meenakshi Singh Also directs: Ravian Pharmaceuticals Limited, Balaji Pharmatech Private Limited | Director | 16 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Fierce One Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unimax Pharmaceuticals Pvt Ltd | ₹3.76 Cr (FY 2025) | -2.0% | Faridabad, Haryana, India | |||
| Fierce One Pharmaceuticals Private Limitedthis company | ₹3.72 Cr (FY 2024) | -₹70,937 | -0.2% | -20.0% | Roorkee, Uttarakhand, India | |
| Konsyl Pharmaceuticals Private Limited | ₹3.68 Cr (FY 2024) | 35.0% | Sanand, Gujarat, India | |||
| Medose Pharmaceuticals Private Limited | ₹3.68 Cr (FY 2023) | 3.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Fierce One Pharmaceuticals Private Limited, buy the company report.
Legal cases
Fierce One Pharmaceuticals Private Limited has 22 court cases on record: 15 filed by Fierce One Pharmaceuticals, 7 filed against it. 16 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 21 | 7 | 16 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against Priyanka | Pending |
| Supreme Court | Petition | Filed by the company against Biocon Limited | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Biocon Limited | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Biocon Limited | Disposed |
| District court, Dehradun, Uttarakhand | Arbitration matter | Filed against the company by M/S Caspian Pharmaceuticals | Pending |
To see the full case history of Fierce One Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fierce One Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Fierce One Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Fierce One Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Meenakshi Singh was appointed as Director on 16 Dec 2021.
Frequently asked questions
Fierce One Pharmaceuticals is an active private limited company based in Roorkee, Uttarakhand, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 16 December 2021 (5+ years old) and is registered under CIN U24239UR2021PTC013370.
Fierce One Pharmaceuticals has 2 current directors:
- Utkarsh Singh - Director
- Meenakshi Singh - Director
The latest financial statements of Fierce One Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Fierce One Pharmaceuticals is U24239UR2021PTC013370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fierce One Pharmaceuticals has 22 court cases on record: 15 filed by the company and 7 filed against it. 16 are pending. Most are in the district courts.
Fierce One Pharmaceuticals was incorporated on 16 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Fierce One Pharmaceuticals by revenue are Unimax Pharmaceuticals Pvt Ltd, Konsyl Pharmaceuticals Private Limited, Medose Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Meenakshi Singh was appointed as Director on 16 Dec 2021. Utkarsh Singh was appointed as Director on 16 Dec 2021.
Yes, Fierce One Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0011110).
The registered office of Fierce One Pharmaceuticals is at Khasra No – 1075M 1076M 7081M Village Salempur Rajputana, Industrial Area Roorkee, Uttarakhand, India – 247667.
Fierce One Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

